Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
9,144
archived clinical trials in
Ocular

Multicenter Post-Approval Study Of The Glaukos® iStent® Trabecular Micro-Bypass Stent System In Conjunction With Cataract Surgery
A Prospective, Controlled, Multicenter Post-Approval Study Of The Glaukos® iStent® Trabecular Micro-Bypass Stent System In Conjunction With Cataract Surgery
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Kingston, PA
Multicenter Post-Approval Study Of The Glaukos® iStent® Trabecular Micro-Bypass Stent System In Conjunction With Cataract Surgery
A Prospective, Controlled, Multicenter Post-Approval Study Of The Glaukos® iStent® Trabecular Micro-Bypass Stent System In Conjunction With Cataract Surgery
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Kingston, PA
Click here to add this to my saved trials
Multicenter Post-Approval Study Of The Glaukos® iStent® Trabecular Micro-Bypass Stent System In Conjunction With Cataract Surgery
A Prospective, Controlled, Multicenter Post-Approval Study Of The Glaukos® iStent® Trabecular Micro-Bypass Stent System In Conjunction With Cataract Surgery
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Saint Joseph, MI
Multicenter Post-Approval Study Of The Glaukos® iStent® Trabecular Micro-Bypass Stent System In Conjunction With Cataract Surgery
A Prospective, Controlled, Multicenter Post-Approval Study Of The Glaukos® iStent® Trabecular Micro-Bypass Stent System In Conjunction With Cataract Surgery
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Saint Joseph, MI
Click here to add this to my saved trials
Multicenter Post-Approval Study Of The Glaukos® iStent® Trabecular Micro-Bypass Stent System In Conjunction With Cataract Surgery
A Prospective, Controlled, Multicenter Post-Approval Study Of The Glaukos® iStent® Trabecular Micro-Bypass Stent System In Conjunction With Cataract Surgery
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Saint Louis, MO
Multicenter Post-Approval Study Of The Glaukos® iStent® Trabecular Micro-Bypass Stent System In Conjunction With Cataract Surgery
A Prospective, Controlled, Multicenter Post-Approval Study Of The Glaukos® iStent® Trabecular Micro-Bypass Stent System In Conjunction With Cataract Surgery
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Saint Louis, MO
Click here to add this to my saved trials
A Multi-Center Study of the Safety and Efficacy of Bevacizumab in High-Risk Corneal Transplant Survival
A Multi-Center Study of the Safety and Efficacy of Bevacizumab in High-Risk Corneal Transplant Survival
Status: Enrolling
Updated:  12/31/1969
Bascom Palmer Eye Institute
mi
from
Miami, FL
A Multi-Center Study of the Safety and Efficacy of Bevacizumab in High-Risk Corneal Transplant Survival
A Multi-Center Study of the Safety and Efficacy of Bevacizumab in High-Risk Corneal Transplant Survival
Status: Enrolling
Updated: 12/31/1969
Bascom Palmer Eye Institute
mi
from
Miami, FL
Click here to add this to my saved trials
A Multi-Center Study of the Safety and Efficacy of Bevacizumab in High-Risk Corneal Transplant Survival
A Multi-Center Study of the Safety and Efficacy of Bevacizumab in High-Risk Corneal Transplant Survival
Status: Enrolling
Updated:  12/31/1969
Massachusetts Eye & Ear Infirmary
mi
from
Boston, MA
A Multi-Center Study of the Safety and Efficacy of Bevacizumab in High-Risk Corneal Transplant Survival
A Multi-Center Study of the Safety and Efficacy of Bevacizumab in High-Risk Corneal Transplant Survival
Status: Enrolling
Updated: 12/31/1969
Massachusetts Eye & Ear Infirmary
mi
from
Boston, MA
Click here to add this to my saved trials
A Multi-Center Study of the Safety and Efficacy of Bevacizumab in High-Risk Corneal Transplant Survival
A Multi-Center Study of the Safety and Efficacy of Bevacizumab in High-Risk Corneal Transplant Survival
Status: Enrolling
Updated:  12/31/1969
New York-Presbyterian Hospital
mi
from
New York, NY
A Multi-Center Study of the Safety and Efficacy of Bevacizumab in High-Risk Corneal Transplant Survival
A Multi-Center Study of the Safety and Efficacy of Bevacizumab in High-Risk Corneal Transplant Survival
Status: Enrolling
Updated: 12/31/1969
New York-Presbyterian Hospital
mi
from
New York, NY
Click here to add this to my saved trials
Loteprednol Ophthalmic Gel for the Treatment of Ocular Inflammation and Pain Following Cataract Surgery
Loteprednol Etabonate Ophthalmic Gel, 0.38% (BID and TID) Versus Vehicle Gel for the Treatment of Ocular Inflammation and Pain Following Cataract Surgery
Status: Enrolling
Updated:  12/31/1969
Bausch & Lomb Incorporated
mi
from
Bridgewater, NJ
Loteprednol Ophthalmic Gel for the Treatment of Ocular Inflammation and Pain Following Cataract Surgery
Loteprednol Etabonate Ophthalmic Gel, 0.38% (BID and TID) Versus Vehicle Gel for the Treatment of Ocular Inflammation and Pain Following Cataract Surgery
Status: Enrolling
Updated: 12/31/1969
Bausch & Lomb Incorporated
mi
from
Bridgewater, NJ
Click here to add this to my saved trials
Phase 2 Study of a New Ophthalmic Formulation of Cyclosporine (Restasis® X) in Patients With Dry Eye Disease
A Phase 2, Multi-center, Vehicle- and Sham-controlled, Randomized Study of RESTASIS® X in Patients With Moderate to Severe Dry Eye Disease
Status: Enrolling
Updated:  12/31/1969
Sall Research Medical Center, Inc.
mi
from
Artesia, CA
Phase 2 Study of a New Ophthalmic Formulation of Cyclosporine (Restasis® X) in Patients With Dry Eye Disease
A Phase 2, Multi-center, Vehicle- and Sham-controlled, Randomized Study of RESTASIS® X in Patients With Moderate to Severe Dry Eye Disease
Status: Enrolling
Updated: 12/31/1969
Sall Research Medical Center, Inc.
mi
from
Artesia, CA
Click here to add this to my saved trials
Phase 2 Study of a New Ophthalmic Formulation of Cyclosporine (Restasis® X) in Patients With Dry Eye Disease
A Phase 2, Multi-center, Vehicle- and Sham-controlled, Randomized Study of RESTASIS® X in Patients With Moderate to Severe Dry Eye Disease
Status: Enrolling
Updated:  12/31/1969
Lugene Eye Institute
mi
from
Glendale, CA
Phase 2 Study of a New Ophthalmic Formulation of Cyclosporine (Restasis® X) in Patients With Dry Eye Disease
A Phase 2, Multi-center, Vehicle- and Sham-controlled, Randomized Study of RESTASIS® X in Patients With Moderate to Severe Dry Eye Disease
Status: Enrolling
Updated: 12/31/1969
Lugene Eye Institute
mi
from
Glendale, CA
Click here to add this to my saved trials
Phase 2 Study of a New Ophthalmic Formulation of Cyclosporine (Restasis® X) in Patients With Dry Eye Disease
A Phase 2, Multi-center, Vehicle- and Sham-controlled, Randomized Study of RESTASIS® X in Patients With Moderate to Severe Dry Eye Disease
Status: Enrolling
Updated:  12/31/1969
Lakeside Vision Center
mi
from
Irvine, CA
Phase 2 Study of a New Ophthalmic Formulation of Cyclosporine (Restasis® X) in Patients With Dry Eye Disease
A Phase 2, Multi-center, Vehicle- and Sham-controlled, Randomized Study of RESTASIS® X in Patients With Moderate to Severe Dry Eye Disease
Status: Enrolling
Updated: 12/31/1969
Lakeside Vision Center
mi
from
Irvine, CA
Click here to add this to my saved trials
Phase 2 Study of a New Ophthalmic Formulation of Cyclosporine (Restasis® X) in Patients With Dry Eye Disease
A Phase 2, Multi-center, Vehicle- and Sham-controlled, Randomized Study of RESTASIS® X in Patients With Moderate to Severe Dry Eye Disease
Status: Enrolling
Updated:  12/31/1969
Wolstan & Goldberg Eye Associates
mi
from
Torrance, CA
Phase 2 Study of a New Ophthalmic Formulation of Cyclosporine (Restasis® X) in Patients With Dry Eye Disease
A Phase 2, Multi-center, Vehicle- and Sham-controlled, Randomized Study of RESTASIS® X in Patients With Moderate to Severe Dry Eye Disease
Status: Enrolling
Updated: 12/31/1969
Wolstan & Goldberg Eye Associates
mi
from
Torrance, CA
Click here to add this to my saved trials
Phase 2 Study of a New Ophthalmic Formulation of Cyclosporine (Restasis® X) in Patients With Dry Eye Disease
A Phase 2, Multi-center, Vehicle- and Sham-controlled, Randomized Study of RESTASIS® X in Patients With Moderate to Severe Dry Eye Disease
Status: Enrolling
Updated:  12/31/1969
Vision Institute
mi
from
Colorado Springs, CO
Phase 2 Study of a New Ophthalmic Formulation of Cyclosporine (Restasis® X) in Patients With Dry Eye Disease
A Phase 2, Multi-center, Vehicle- and Sham-controlled, Randomized Study of RESTASIS® X in Patients With Moderate to Severe Dry Eye Disease
Status: Enrolling
Updated: 12/31/1969
Vision Institute
mi
from
Colorado Springs, CO
Click here to add this to my saved trials
Phase 2 Study of a New Ophthalmic Formulation of Cyclosporine (Restasis® X) in Patients With Dry Eye Disease
A Phase 2, Multi-center, Vehicle- and Sham-controlled, Randomized Study of RESTASIS® X in Patients With Moderate to Severe Dry Eye Disease
Status: Enrolling
Updated:  12/31/1969
Johns Hopkins University Wilmer Eye Institute
mi
from
Baltimore, MD
Phase 2 Study of a New Ophthalmic Formulation of Cyclosporine (Restasis® X) in Patients With Dry Eye Disease
A Phase 2, Multi-center, Vehicle- and Sham-controlled, Randomized Study of RESTASIS® X in Patients With Moderate to Severe Dry Eye Disease
Status: Enrolling
Updated: 12/31/1969
Johns Hopkins University Wilmer Eye Institute
mi
from
Baltimore, MD
Click here to add this to my saved trials
Phase 2 Study of a New Ophthalmic Formulation of Cyclosporine (Restasis® X) in Patients With Dry Eye Disease
A Phase 2, Multi-center, Vehicle- and Sham-controlled, Randomized Study of RESTASIS® X in Patients With Moderate to Severe Dry Eye Disease
Status: Enrolling
Updated:  12/31/1969
Eye Centers of Racine and Kenosha
mi
from
Kenosha, WI
Phase 2 Study of a New Ophthalmic Formulation of Cyclosporine (Restasis® X) in Patients With Dry Eye Disease
A Phase 2, Multi-center, Vehicle- and Sham-controlled, Randomized Study of RESTASIS® X in Patients With Moderate to Severe Dry Eye Disease
Status: Enrolling
Updated: 12/31/1969
Eye Centers of Racine and Kenosha
mi
from
Kenosha, WI
Click here to add this to my saved trials
Phase 2 Study of a New Ophthalmic Formulation of Cyclosporine (Restasis® X) in Patients With Dry Eye Disease
A Phase 2, Multi-center, Vehicle- and Sham-controlled, Randomized Study of RESTASIS® X in Patients With Moderate to Severe Dry Eye Disease
Status: Enrolling
Updated:  12/31/1969
Steve Yoelin MD Medical Asscociates
mi
from
Newport Beach, CA
Phase 2 Study of a New Ophthalmic Formulation of Cyclosporine (Restasis® X) in Patients With Dry Eye Disease
A Phase 2, Multi-center, Vehicle- and Sham-controlled, Randomized Study of RESTASIS® X in Patients With Moderate to Severe Dry Eye Disease
Status: Enrolling
Updated: 12/31/1969
Steve Yoelin MD Medical Asscociates
mi
from
Newport Beach, CA
Click here to add this to my saved trials
Family Myopia Study
Family Myopia Study
Status: Enrolling
Updated:  12/31/1969
National Human Genome Research Institute (NHGRI), 9000 Rockville Pike
mi
from
Bethesda, MD
Family Myopia Study
Family Myopia Study
Status: Enrolling
Updated: 12/31/1969
National Human Genome Research Institute (NHGRI), 9000 Rockville Pike
mi
from
Bethesda, MD
Click here to add this to my saved trials
Safety and Efficacy of T-2345 Compared to Xalatan in Subjects With Primary Open Angle Glaucoma or Ocular Hypertension
A Randomized, Multicenter, Parallel-Group, Observer-Masked, Phase 3 Study to Compare the Safety and Efficacy of T-2345 Ophthalmic Solution to Xalatan (Latanoprost 0.005%) in Subjects With Primary Open Angle Glaucoma or Ocular Hypertension
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
El Paso, TX
Safety and Efficacy of T-2345 Compared to Xalatan in Subjects With Primary Open Angle Glaucoma or Ocular Hypertension
A Randomized, Multicenter, Parallel-Group, Observer-Masked, Phase 3 Study to Compare the Safety and Efficacy of T-2345 Ophthalmic Solution to Xalatan (Latanoprost 0.005%) in Subjects With Primary Open Angle Glaucoma or Ocular Hypertension
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
El Paso, TX
Click here to add this to my saved trials
Evaluation of Etafilcon A Daily Disposable Lenses
Clinical Evaluation of Two Etafilcon A Daily Disposable Lenses
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Jacksonville, FL
Evaluation of Etafilcon A Daily Disposable Lenses
Clinical Evaluation of Two Etafilcon A Daily Disposable Lenses
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Jacksonville, FL
Click here to add this to my saved trials
Evaluation of Etafilcon A Daily Disposable Lenses
Clinical Evaluation of Two Etafilcon A Daily Disposable Lenses
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Honolulu, HI
Evaluation of Etafilcon A Daily Disposable Lenses
Clinical Evaluation of Two Etafilcon A Daily Disposable Lenses
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Honolulu, HI
Click here to add this to my saved trials
Evaluation of Etafilcon A Daily Disposable Lenses
Clinical Evaluation of Two Etafilcon A Daily Disposable Lenses
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Waipahu, HI
Evaluation of Etafilcon A Daily Disposable Lenses
Clinical Evaluation of Two Etafilcon A Daily Disposable Lenses
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Waipahu, HI
Click here to add this to my saved trials
Evaluation of Etafilcon A Daily Disposable Lenses
Clinical Evaluation of Two Etafilcon A Daily Disposable Lenses
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
New York, NY
Evaluation of Etafilcon A Daily Disposable Lenses
Clinical Evaluation of Two Etafilcon A Daily Disposable Lenses
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
New York, NY
Click here to add this to my saved trials
Evaluation of Etafilcon A Daily Disposable Lenses
Clinical Evaluation of Two Etafilcon A Daily Disposable Lenses
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Houston, TX
Evaluation of Etafilcon A Daily Disposable Lenses
Clinical Evaluation of Two Etafilcon A Daily Disposable Lenses
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Houston, TX
Click here to add this to my saved trials
Evaluation of Etafilcon A Daily Disposable Lenses
Clinical Evaluation of Two Etafilcon A Daily Disposable Lenses
Status: Enrolling
Updated:  12/31/1969
Research Site
mi
from
'Aiea, HI
Evaluation of Etafilcon A Daily Disposable Lenses
Clinical Evaluation of Two Etafilcon A Daily Disposable Lenses
Status: Enrolling
Updated: 12/31/1969
Research Site
mi
from
'Aiea, HI
Click here to add this to my saved trials
Evaluation of Etafilcon A Daily Disposable Lenses
Clinical Evaluation of Two Etafilcon A Daily Disposable Lenses
Status: Enrolling
Updated:  12/31/1969
mi
from
Kahului, HI
Evaluation of Etafilcon A Daily Disposable Lenses
Clinical Evaluation of Two Etafilcon A Daily Disposable Lenses
Status: Enrolling
Updated: 12/31/1969
mi
from
Kahului, HI
Click here to add this to my saved trials
Phase II Combination Steroid and Anti-VEGF for Persistent DME
Short-term Evaluation of Combination Corticosteroid+Anti-VEGF Treatment for Persistent Central-Involved Diabetic Macular Edema Following Anti-VEGF Therapy
Status: Enrolling
Updated:  12/31/1969
Retina-Vitreous Associates Medical Group
mi
from
Beverly Hills, CA
Phase II Combination Steroid and Anti-VEGF for Persistent DME
Short-term Evaluation of Combination Corticosteroid+Anti-VEGF Treatment for Persistent Central-Involved Diabetic Macular Edema Following Anti-VEGF Therapy
Status: Enrolling
Updated: 12/31/1969
Retina-Vitreous Associates Medical Group
mi
from
Beverly Hills, CA
Click here to add this to my saved trials
Phase II Combination Steroid and Anti-VEGF for Persistent DME
Short-term Evaluation of Combination Corticosteroid+Anti-VEGF Treatment for Persistent Central-Involved Diabetic Macular Edema Following Anti-VEGF Therapy
Status: Enrolling
Updated:  12/31/1969
Loma Linda University Health Care, Dept. of Ophthalmology
mi
from
Loma Linda, CA
Phase II Combination Steroid and Anti-VEGF for Persistent DME
Short-term Evaluation of Combination Corticosteroid+Anti-VEGF Treatment for Persistent Central-Involved Diabetic Macular Edema Following Anti-VEGF Therapy
Status: Enrolling
Updated: 12/31/1969
Loma Linda University Health Care, Dept. of Ophthalmology
mi
from
Loma Linda, CA
Click here to add this to my saved trials
Phase II Combination Steroid and Anti-VEGF for Persistent DME
Short-term Evaluation of Combination Corticosteroid+Anti-VEGF Treatment for Persistent Central-Involved Diabetic Macular Edema Following Anti-VEGF Therapy
Status: Enrolling
Updated:  12/31/1969
Retina Consultants of Southern California
mi
from
Redlands, CA
Phase II Combination Steroid and Anti-VEGF for Persistent DME
Short-term Evaluation of Combination Corticosteroid+Anti-VEGF Treatment for Persistent Central-Involved Diabetic Macular Edema Following Anti-VEGF Therapy
Status: Enrolling
Updated: 12/31/1969
Retina Consultants of Southern California
mi
from
Redlands, CA
Click here to add this to my saved trials
Phase II Combination Steroid and Anti-VEGF for Persistent DME
Short-term Evaluation of Combination Corticosteroid+Anti-VEGF Treatment for Persistent Central-Involved Diabetic Macular Edema Following Anti-VEGF Therapy
Status: Enrolling
Updated:  12/31/1969
Retinal Consultants Medical Group, Inc.
mi
from
Sacramento, CA
Phase II Combination Steroid and Anti-VEGF for Persistent DME
Short-term Evaluation of Combination Corticosteroid+Anti-VEGF Treatment for Persistent Central-Involved Diabetic Macular Edema Following Anti-VEGF Therapy
Status: Enrolling
Updated: 12/31/1969
Retinal Consultants Medical Group, Inc.
mi
from
Sacramento, CA
Click here to add this to my saved trials
Phase II Combination Steroid and Anti-VEGF for Persistent DME
Short-term Evaluation of Combination Corticosteroid+Anti-VEGF Treatment for Persistent Central-Involved Diabetic Macular Edema Following Anti-VEGF Therapy
Status: Enrolling
Updated:  12/31/1969
California Retina Consultants
mi
from
Santa Barbara, CA
Phase II Combination Steroid and Anti-VEGF for Persistent DME
Short-term Evaluation of Combination Corticosteroid+Anti-VEGF Treatment for Persistent Central-Involved Diabetic Macular Edema Following Anti-VEGF Therapy
Status: Enrolling
Updated: 12/31/1969
California Retina Consultants
mi
from
Santa Barbara, CA
Click here to add this to my saved trials
Phase II Combination Steroid and Anti-VEGF for Persistent DME
Short-term Evaluation of Combination Corticosteroid+Anti-VEGF Treatment for Persistent Central-Involved Diabetic Macular Edema Following Anti-VEGF Therapy
Status: Enrolling
Updated:  12/31/1969
Bay Area Retina Associates
mi
from
Walnut Creek, CA
Phase II Combination Steroid and Anti-VEGF for Persistent DME
Short-term Evaluation of Combination Corticosteroid+Anti-VEGF Treatment for Persistent Central-Involved Diabetic Macular Edema Following Anti-VEGF Therapy
Status: Enrolling
Updated: 12/31/1969
Bay Area Retina Associates
mi
from
Walnut Creek, CA
Click here to add this to my saved trials
Phase II Combination Steroid and Anti-VEGF for Persistent DME
Short-term Evaluation of Combination Corticosteroid+Anti-VEGF Treatment for Persistent Central-Involved Diabetic Macular Edema Following Anti-VEGF Therapy
Status: Enrolling
Updated:  12/31/1969
New England Retina Associates
mi
from
Norwich, CT
Phase II Combination Steroid and Anti-VEGF for Persistent DME
Short-term Evaluation of Combination Corticosteroid+Anti-VEGF Treatment for Persistent Central-Involved Diabetic Macular Edema Following Anti-VEGF Therapy
Status: Enrolling
Updated: 12/31/1969
New England Retina Associates
mi
from
Norwich, CT
Click here to add this to my saved trials
Phase II Combination Steroid and Anti-VEGF for Persistent DME
Short-term Evaluation of Combination Corticosteroid+Anti-VEGF Treatment for Persistent Central-Involved Diabetic Macular Edema Following Anti-VEGF Therapy
Status: Enrolling
Updated:  12/31/1969
National Ophthalmic Research Institute
mi
from
Fort Myers, FL
Phase II Combination Steroid and Anti-VEGF for Persistent DME
Short-term Evaluation of Combination Corticosteroid+Anti-VEGF Treatment for Persistent Central-Involved Diabetic Macular Edema Following Anti-VEGF Therapy
Status: Enrolling
Updated: 12/31/1969
National Ophthalmic Research Institute
mi
from
Fort Myers, FL
Click here to add this to my saved trials
Phase II Combination Steroid and Anti-VEGF for Persistent DME
Short-term Evaluation of Combination Corticosteroid+Anti-VEGF Treatment for Persistent Central-Involved Diabetic Macular Edema Following Anti-VEGF Therapy
Status: Enrolling
Updated:  12/31/1969
University of Florida College of Med., Department of Ophthalmology
mi
from
Jacksonville, FL
Phase II Combination Steroid and Anti-VEGF for Persistent DME
Short-term Evaluation of Combination Corticosteroid+Anti-VEGF Treatment for Persistent Central-Involved Diabetic Macular Edema Following Anti-VEGF Therapy
Status: Enrolling
Updated: 12/31/1969
University of Florida College of Med., Department of Ophthalmology
mi
from
Jacksonville, FL
Click here to add this to my saved trials
Phase II Combination Steroid and Anti-VEGF for Persistent DME
Short-term Evaluation of Combination Corticosteroid+Anti-VEGF Treatment for Persistent Central-Involved Diabetic Macular Edema Following Anti-VEGF Therapy
Status: Enrolling
Updated:  12/31/1969
Central Florida Retina Institute
mi
from
Lakeland, FL
Phase II Combination Steroid and Anti-VEGF for Persistent DME
Short-term Evaluation of Combination Corticosteroid+Anti-VEGF Treatment for Persistent Central-Involved Diabetic Macular Edema Following Anti-VEGF Therapy
Status: Enrolling
Updated: 12/31/1969
Central Florida Retina Institute
mi
from
Lakeland, FL
Click here to add this to my saved trials
Phase II Combination Steroid and Anti-VEGF for Persistent DME
Short-term Evaluation of Combination Corticosteroid+Anti-VEGF Treatment for Persistent Central-Involved Diabetic Macular Edema Following Anti-VEGF Therapy
Status: Enrolling
Updated:  12/31/1969
Ocala Eye Retina Consultants
mi
from
Ocala, FL
Phase II Combination Steroid and Anti-VEGF for Persistent DME
Short-term Evaluation of Combination Corticosteroid+Anti-VEGF Treatment for Persistent Central-Involved Diabetic Macular Edema Following Anti-VEGF Therapy
Status: Enrolling
Updated: 12/31/1969
Ocala Eye Retina Consultants
mi
from
Ocala, FL
Click here to add this to my saved trials
Phase II Combination Steroid and Anti-VEGF for Persistent DME
Short-term Evaluation of Combination Corticosteroid+Anti-VEGF Treatment for Persistent Central-Involved Diabetic Macular Edema Following Anti-VEGF Therapy
Status: Enrolling
Updated:  12/31/1969
Sarasota Retina Institute
mi
from
Sarasota, FL
Phase II Combination Steroid and Anti-VEGF for Persistent DME
Short-term Evaluation of Combination Corticosteroid+Anti-VEGF Treatment for Persistent Central-Involved Diabetic Macular Edema Following Anti-VEGF Therapy
Status: Enrolling
Updated: 12/31/1969
Sarasota Retina Institute
mi
from
Sarasota, FL
Click here to add this to my saved trials
Phase II Combination Steroid and Anti-VEGF for Persistent DME
Short-term Evaluation of Combination Corticosteroid+Anti-VEGF Treatment for Persistent Central-Involved Diabetic Macular Edema Following Anti-VEGF Therapy
Status: Enrolling
Updated:  12/31/1969
Retina Associates of Florida, P.A.
mi
from
Tampa, FL
Phase II Combination Steroid and Anti-VEGF for Persistent DME
Short-term Evaluation of Combination Corticosteroid+Anti-VEGF Treatment for Persistent Central-Involved Diabetic Macular Edema Following Anti-VEGF Therapy
Status: Enrolling
Updated: 12/31/1969
Retina Associates of Florida, P.A.
mi
from
Tampa, FL
Click here to add this to my saved trials
Phase II Combination Steroid and Anti-VEGF for Persistent DME
Short-term Evaluation of Combination Corticosteroid+Anti-VEGF Treatment for Persistent Central-Involved Diabetic Macular Edema Following Anti-VEGF Therapy
Status: Enrolling
Updated:  12/31/1969
Southeast Retina Center, P.C.
mi
from
Augusta, GA
Phase II Combination Steroid and Anti-VEGF for Persistent DME
Short-term Evaluation of Combination Corticosteroid+Anti-VEGF Treatment for Persistent Central-Involved Diabetic Macular Edema Following Anti-VEGF Therapy
Status: Enrolling
Updated: 12/31/1969
Southeast Retina Center, P.C.
mi
from
Augusta, GA
Click here to add this to my saved trials
Phase II Combination Steroid and Anti-VEGF for Persistent DME
Short-term Evaluation of Combination Corticosteroid+Anti-VEGF Treatment for Persistent Central-Involved Diabetic Macular Edema Following Anti-VEGF Therapy
Status: Enrolling
Updated:  12/31/1969
Raj K. Maturi, MD
mi
from
Indianapolis, IN
Phase II Combination Steroid and Anti-VEGF for Persistent DME
Short-term Evaluation of Combination Corticosteroid+Anti-VEGF Treatment for Persistent Central-Involved Diabetic Macular Edema Following Anti-VEGF Therapy
Status: Enrolling
Updated: 12/31/1969
Raj K. Maturi, MD
mi
from
Indianapolis, IN
Click here to add this to my saved trials
Phase II Combination Steroid and Anti-VEGF for Persistent DME
Short-term Evaluation of Combination Corticosteroid+Anti-VEGF Treatment for Persistent Central-Involved Diabetic Macular Edema Following Anti-VEGF Therapy
Status: Enrolling
Updated:  12/31/1969
Wolfe Eye Clinic
mi
from
West Des Moines, IA
Phase II Combination Steroid and Anti-VEGF for Persistent DME
Short-term Evaluation of Combination Corticosteroid+Anti-VEGF Treatment for Persistent Central-Involved Diabetic Macular Edema Following Anti-VEGF Therapy
Status: Enrolling
Updated: 12/31/1969
Wolfe Eye Clinic
mi
from
West Des Moines, IA
Click here to add this to my saved trials
Phase II Combination Steroid and Anti-VEGF for Persistent DME
Short-term Evaluation of Combination Corticosteroid+Anti-VEGF Treatment for Persistent Central-Involved Diabetic Macular Edema Following Anti-VEGF Therapy
Status: Enrolling
Updated:  12/31/1969
Elman Retina Group, PA
mi
from
Baltimore, MD
Phase II Combination Steroid and Anti-VEGF for Persistent DME
Short-term Evaluation of Combination Corticosteroid+Anti-VEGF Treatment for Persistent Central-Involved Diabetic Macular Edema Following Anti-VEGF Therapy
Status: Enrolling
Updated: 12/31/1969
Elman Retina Group, PA
mi
from
Baltimore, MD
Click here to add this to my saved trials
Phase II Combination Steroid and Anti-VEGF for Persistent DME
Short-term Evaluation of Combination Corticosteroid+Anti-VEGF Treatment for Persistent Central-Involved Diabetic Macular Edema Following Anti-VEGF Therapy
Status: Enrolling
Updated:  12/31/1969
National Eye Institute/National Institutes of Health
mi
from
Bethesda, MD
Phase II Combination Steroid and Anti-VEGF for Persistent DME
Short-term Evaluation of Combination Corticosteroid+Anti-VEGF Treatment for Persistent Central-Involved Diabetic Macular Edema Following Anti-VEGF Therapy
Status: Enrolling
Updated: 12/31/1969
National Eye Institute/National Institutes of Health
mi
from
Bethesda, MD
Click here to add this to my saved trials
Phase II Combination Steroid and Anti-VEGF for Persistent DME
Short-term Evaluation of Combination Corticosteroid+Anti-VEGF Treatment for Persistent Central-Involved Diabetic Macular Edema Following Anti-VEGF Therapy
Status: Enrolling
Updated:  12/31/1969
Ophthalmic Consultants of Boston
mi
from
Boston, MA
Phase II Combination Steroid and Anti-VEGF for Persistent DME
Short-term Evaluation of Combination Corticosteroid+Anti-VEGF Treatment for Persistent Central-Involved Diabetic Macular Edema Following Anti-VEGF Therapy
Status: Enrolling
Updated: 12/31/1969
Ophthalmic Consultants of Boston
mi
from
Boston, MA
Click here to add this to my saved trials
Phase II Combination Steroid and Anti-VEGF for Persistent DME
Short-term Evaluation of Combination Corticosteroid+Anti-VEGF Treatment for Persistent Central-Involved Diabetic Macular Edema Following Anti-VEGF Therapy
Status: Enrolling
Updated:  12/31/1969
Joslin Diabetes Center
mi
from
Boston, MA
Phase II Combination Steroid and Anti-VEGF for Persistent DME
Short-term Evaluation of Combination Corticosteroid+Anti-VEGF Treatment for Persistent Central-Involved Diabetic Macular Edema Following Anti-VEGF Therapy
Status: Enrolling
Updated: 12/31/1969
Joslin Diabetes Center
mi
from
Boston, MA
Click here to add this to my saved trials
Phase II Combination Steroid and Anti-VEGF for Persistent DME
Short-term Evaluation of Combination Corticosteroid+Anti-VEGF Treatment for Persistent Central-Involved Diabetic Macular Edema Following Anti-VEGF Therapy
Status: Enrolling
Updated:  12/31/1969
Retina Vitreous Center
mi
from
Grand Blanc, MI
Phase II Combination Steroid and Anti-VEGF for Persistent DME
Short-term Evaluation of Combination Corticosteroid+Anti-VEGF Treatment for Persistent Central-Involved Diabetic Macular Edema Following Anti-VEGF Therapy
Status: Enrolling
Updated: 12/31/1969
Retina Vitreous Center
mi
from
Grand Blanc, MI
Click here to add this to my saved trials
Phase II Combination Steroid and Anti-VEGF for Persistent DME
Short-term Evaluation of Combination Corticosteroid+Anti-VEGF Treatment for Persistent Central-Involved Diabetic Macular Edema Following Anti-VEGF Therapy
Status: Enrolling
Updated:  12/31/1969
Retina Specialists of Michigan
mi
from
Grand Rapids, MI
Phase II Combination Steroid and Anti-VEGF for Persistent DME
Short-term Evaluation of Combination Corticosteroid+Anti-VEGF Treatment for Persistent Central-Involved Diabetic Macular Edema Following Anti-VEGF Therapy
Status: Enrolling
Updated: 12/31/1969
Retina Specialists of Michigan
mi
from
Grand Rapids, MI
Click here to add this to my saved trials
Phase II Combination Steroid and Anti-VEGF for Persistent DME
Short-term Evaluation of Combination Corticosteroid+Anti-VEGF Treatment for Persistent Central-Involved Diabetic Macular Edema Following Anti-VEGF Therapy
Status: Enrolling
Updated:  12/31/1969
The Retina Center
mi
from
Minneapolis, MN
Phase II Combination Steroid and Anti-VEGF for Persistent DME
Short-term Evaluation of Combination Corticosteroid+Anti-VEGF Treatment for Persistent Central-Involved Diabetic Macular Edema Following Anti-VEGF Therapy
Status: Enrolling
Updated: 12/31/1969
The Retina Center
mi
from
Minneapolis, MN
Click here to add this to my saved trials
Phase II Combination Steroid and Anti-VEGF for Persistent DME
Short-term Evaluation of Combination Corticosteroid+Anti-VEGF Treatment for Persistent Central-Involved Diabetic Macular Edema Following Anti-VEGF Therapy
Status: Enrolling
Updated:  12/31/1969
The Institute of Ophthalmology and Visual Science (IOVS)
mi
from
Newark, NJ
Phase II Combination Steroid and Anti-VEGF for Persistent DME
Short-term Evaluation of Combination Corticosteroid+Anti-VEGF Treatment for Persistent Central-Involved Diabetic Macular Edema Following Anti-VEGF Therapy
Status: Enrolling
Updated: 12/31/1969
The Institute of Ophthalmology and Visual Science (IOVS)
mi
from
Newark, NJ
Click here to add this to my saved trials
Phase II Combination Steroid and Anti-VEGF for Persistent DME
Short-term Evaluation of Combination Corticosteroid+Anti-VEGF Treatment for Persistent Central-Involved Diabetic Macular Edema Following Anti-VEGF Therapy
Status: Enrolling
Updated:  12/31/1969
MaculaCare
mi
from
New York, NY
Phase II Combination Steroid and Anti-VEGF for Persistent DME
Short-term Evaluation of Combination Corticosteroid+Anti-VEGF Treatment for Persistent Central-Involved Diabetic Macular Edema Following Anti-VEGF Therapy
Status: Enrolling
Updated: 12/31/1969
MaculaCare
mi
from
New York, NY
Click here to add this to my saved trials
Phase II Combination Steroid and Anti-VEGF for Persistent DME
Short-term Evaluation of Combination Corticosteroid+Anti-VEGF Treatment for Persistent Central-Involved Diabetic Macular Edema Following Anti-VEGF Therapy
Status: Enrolling
Updated:  12/31/1969
Retina Associates of Western New York
mi
from
Rochester, NY
Phase II Combination Steroid and Anti-VEGF for Persistent DME
Short-term Evaluation of Combination Corticosteroid+Anti-VEGF Treatment for Persistent Central-Involved Diabetic Macular Edema Following Anti-VEGF Therapy
Status: Enrolling
Updated: 12/31/1969
Retina Associates of Western New York
mi
from
Rochester, NY
Click here to add this to my saved trials